Ceeable is commercializing the mobile digital health test technology, Ceeable visual field analyzer invented at Caltech. The technology detects and diagnoses retinal disease on a standard tablet. There are more than 285 million people worldwide that suffer from blinding diseases, such as diabetic retinopathy, glaucoma and age related macular degeneration. The CVFA technology has been employed in v
ision clinics in the US, Mexico, Russia and other developed and developing countries. The ever growing number of smart phone and tablet users with internet access across the globe allows Ceeable broad global access to a diversity of patients both at home and in the clinic. Market scale and sustainability is achieved by providing innovative software-based solutions that run on low cost touch-screen tablet and smartphone hardware. Business and market success will position the company to help reduce the incidence of blindness for years to come.
